Cytoprotection by Inhaled Carbon Monoxide before Cardiopulmonary Bypass in Preclinical Models

Publisher： Bentham Science Publishers

E-ISSN： 1873-4316|13|6|797-802

ISSN： 1389-2010

Source： Current Pharmaceutical Biotechnology, Vol.13, Iss.6, 2012-05, pp. : 797-802

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Inhaled Biologics: From Preclinical to Product Approval

By  

Current Pharmaceutical Design, Vol. 22, Iss. 17, 2016-05 ,pp. : 2501-2521

Bentham Science Publishers

Access to resources Recommend Favorite

Carbon Monoxide and the Pancreas

By  

Current Pharmaceutical Biotechnology, Vol. 13, Iss. 6, 2012-05 ,pp. : 813-818

Bentham Science Publishers

Access to resources Recommend Favorite

Application of Carbon Monoxide for Transplantation

By  

Current Pharmaceutical Biotechnology, Vol. 13, Iss. 6, 2012-05 ,pp. : 827-836

Bentham Science Publishers

Access to resources Recommend Favorite

Antibacterial Effects of Carbon Monoxide

By  

Current Pharmaceutical Biotechnology, Vol. 13, Iss. 6, 2012-05 ,pp. : 760-768

Bentham Science Publishers

Access to resources Recommend Favorite

TP 10: safety, pharmacokinetics in cardiopulmonary bypass in infants

By  

Inpharma, Vol. 1, Iss. 1420, 2004-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite